May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Involvement of Distinct SOCS Family Members in Insulin Resistance and Protection of Neuroretina
Author Affiliations & Notes
  • X. Liu
    National Eye Institute, Bethesda, MD
    Laboratory of Immunology,
  • Y. Lee
    National Eye Institute, Bethesda, MD
    Laboratory of Immunology,
  • J. Tsai
    National Eye Institute, Bethesda, MD
    Imaging Core Unit,
  • R. Fariss
    National Eye Institute, Bethesda, MD
    Imaging Core Unit,
  • C. Yu
    National Eye Institute, Bethesda, MD
    Laboratory of Immunology,
  • C.E. Egwuagu
    National Eye Institute, Bethesda, MD
    Laboratory of Immunology,
  • Footnotes
    Commercial Relationships  X. Liu, None; Y. Lee, None; J. Tsai, None; R. Fariss, None; C. Yu, None; C.E. Egwuagu, None.
  • Footnotes
    Support  This Research was supported by The Intramural Research Program of National Eye Institute, NIH
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4229. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      X. Liu, Y. Lee, J. Tsai, R. Fariss, C. Yu, C.E. Egwuagu; Involvement of Distinct SOCS Family Members in Insulin Resistance and Protection of Neuroretina . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4229.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Diabetic retinopathy is one of several ocular complications of diabetes. It is a leading cause of vision loss in developed countries and insulin resistance is implicated in etiology of diabetic retinopathy. Suppressor of cytokine signaling (SOCS) proteins inhibit insulin signals by targeting insulin receptor substrate (IRS) proteins and have recently been shown to induce insulin resistance in hepatic cells. Here, we have assessed the role of SOCS in normal retina, as well as, in retinal cells exposed to inflammatory cytokines.

Methods: : SOCS expression in human or rodent retina was analyzed by RT–PCR or Western blotting and SOCS proteins were localized in mouse retina by immunohistochemical analysis. Functional consequences of SOCS over–expression in retina was determined by transfection of human RPE or Mueller cells with SOCS1 or SOCS3 expression plasmids while effects of SOCS6 depletion in insulin–stimulated retinal cells was assessed by RNA interference assay. SOCS and insulin target genes were analyzed by RPA, EMSA, Western blotting or Real–time RT–PCR.

Results: : We show that SOCS5, SOCS6, and SOCS7 proteins are constitutively expressed in the retina and we have localized expression of these SOCS members to the ganglion cell and photoreceptor cell layers of mouse retina by immunohistochemical analysis. In contrast, SOCS1, SOCS3 or CIS expression is low in the retina but rapidly inducible during inflammation by inflammatory mediators such as IFN–γ and IL–4. Of particular interest is our finding that IFN–γ synergizes with insulin to enhance expression of SOCS1 and SOCS3, resulting in the inhibition of AKT activation in the retina by insulin. Forced over–expression of SOCS1 or SOCS3 in retinal cells is shown to inhibit AKT phosphorylation while siRNA–mediated depletion of SOCS6 inhibits insulin–induced AKT activation, underscoring divergent functions of distinct SOCS proteins in the retina.

Conclusions: : We provide evidence that SOCS proteins are constitutively and inducibly expressed in the retina. Our results showing that IFNγ synergizes with insulin to enhance SOCS expression and inhibit insulin signals in retinal cells, suggest that proinflammatory cytokines produced during inflammation may promote insulin resistance in the retina and contribute to devastating effects associated with ocular manifestation of diabetes. On the other hand, SOCS proteins that are constitutively expressed in the retina such as SOCS6 promote insulin signaling and may have protective functions in the neural retina.

Keywords: inflammation • neuroprotection • retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×